通过MED12抑制NEAT1,在p53野生型乳腺癌细胞中产生化学敏感性
Shengjie Zhang1,2, Eui-Jun Kim1, Junfeng Huang3
1McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, WI, USA.
The FEBS journal
|February 21, 2024
概括
介质复合体子单元12 (MED12) 通过控制NEAT1表达来调节乳腺癌中的化学抵抗. 在野生型p53乳腺癌细胞中,MED12抑制NEAT1对化学抵抗至关重要.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 化学抵抗是乳腺癌治疗的一个主要挑战.
- 长非编码RNA,如NEAT1,与化学抵抗有关.
- 在乳腺癌中NEAT1的精确调节机制仍然不完全理解.
研究的目的:
- 研究乳腺癌中NEAT1的转录调节.
- 阐明 MED12 和 p53 状态在 NEAT1 中介化疗抵抗中的作用.
- 确定克服乳腺癌化学抵抗的新型治疗点.
主要方法:
- 采用多种omics方法来研究NEAT1转录.
- 进行了基因表达分析,包括NEAT1mRNA水平.
- 操纵了MED12和p53表达水平 (例如,敲击),以评估它们的影响.
主要成果:
- NEAT1在野生型p53乳腺癌细胞中被5-甲上调,但在突变型p53细胞中没有.
- 通过NEAT1促进体的表观遗传修饰,MED12抑制NEAT1转录.
- 在野生类型的p53细胞中,MED12枯竭会增加NEAT1的表达和化学抵抗,这种效应被NEAT1的淘汰部分扭转.
结论:
- MED12通过转录调节NEAT1,影响乳腺癌中的化学抵抗.
- p53状态 (野生型与突变型) 显著影响MED12-NEAT1监管轴.
- 针对MED12-NEAT1途径提出了打击特定乳腺癌亚型的化学抵抗的潜在策略.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:23Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
02:37DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K